Literature DB >> 10353696

Activation of protein kinase A by dibutyryl cAMP treatment of NIH 3T3 cells inhibits proliferation but fails to induce Ser-133 phosphorylation and transcriptional activation of CREB.

O M Seternes1, R Sørensen, B Johansen, U Moens.   

Abstract

The cAMP analogue dibutyryl cAMP (dbcAMP) is often used to activate the protein kinase A pathway and to study the expression of cAMP-responsive genes. Here we show that in NIH 3T3 cells dbcAMP is able to activate PKA, but fails to stimulate expression of the cAMP-inducible c-fos gene. Co-expression of A-kinase anchoring protein 75, previously shown to amplify cAMP signalling and to stimulate c-fos expression, could not restore cAMP responsiveness of the c-fos promoter. DbcAMP-induced activation of PKA may result in poor translocation of the catalytic sub-units of PKA to the nucleus, indicated by the lack of both Ser-133 phosphorylation of the cAMP-response element binding factor CREB and stimulation of the transcriptional activity of this factor. DbcAMP treatment, however, inhibited cell proliferation. These results suggest that cAMP-mediated inhibition of proliferation may be independent of translocation of the catalytic sub-units into the nucleus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10353696     DOI: 10.1016/s0898-6568(98)00069-2

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  6 in total

1.  Differential impact of acute and prolonged cAMP agonist exposure on protein kinase A activation and human myometrium contractile activity.

Authors:  Pei F Lai; Rachel M Tribe; Mark R Johnson
Journal:  J Physiol       Date:  2016-08-08       Impact factor: 5.182

2.  Tissue-specific transgenic knockdown of Fos-related antigen 2 (Fra-2) expression mediated by dominant negative Fra-2.

Authors:  M Smith; Z Burke; A Humphries; T Wells; D Klein; D Carter; R Baler
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

3.  ACTH receptor: ectopic expression, activity and signaling.

Authors:  Fábio Luís Forti; Matheus H S Dias; Hugo Aguirre Armelin
Journal:  Mol Cell Biochem       Date:  2006-07-15       Impact factor: 3.396

4.  Alzheimer's disease associated AKAP9 I2558M mutation alters posttranslational modification and interactome of tau and cellular functions in CRISPR-edited human neuronal cells.

Authors:  Yang You; Samuel W Hersh; Roshanak Aslebagh; Scott A Shaffer; Seiko Ikezu; Jesse Mez; Kathryn L Lunetta; Mark W Logue; Lindsay A Farrer; Tsuneya Ikezu
Journal:  Aging Cell       Date:  2022-05-14       Impact factor: 11.005

5.  cAMP induces hypertrophy and alters DNA methylation in HL-1 cardiomyocytes.

Authors:  Xiefan Fang; Jourdon Robinson; John Wang-Hu; Lingli Jiang; Daniel A Freeman; Scott A Rivkees; Christopher C Wendler
Journal:  Am J Physiol Cell Physiol       Date:  2015-07-29       Impact factor: 4.249

6.  DbcAMP regulates adipogenesis in sheep inguinal preadipocytes.

Authors:  Delin Kong; Jingjing Cui; Juncai Fu
Journal:  Lipids Health Dis       Date:  2017-05-19       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.